Atlas Trials

Assessment of the Hemodynamic Effect of Hydroxocabalamin in Refractory Vasodilatory Shock

Clinical trial NCT04964492 · COMPLETED

Trial details

NCT number
NCT04964492
Sponsor
Centre Hospitalier Universitaire, Amiens
Status
COMPLETED
Study type
OBSERVATIONAL
VasoplegiaHemodynamicsIntensive Care UnitShock
Start date
2020-01-15
Primary completion
2021-01-08
Enrollment
18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.